Krka Boosts Profit by 6%

Novo Mesto, 27 February - Drug-maker Krka concluded 2003 in line with its plans and strategic guidelines, generating sales revenues of SIT 85.8bn (EUR 361m), which is 10 percent more than in 2002. Krka's net profit increased by 6 percent, totalling over SIT 11bn (EUR 46.3m), show unaudited data published Friday on the Ljubljana Stock Exchange web site.